ELTROMBOPAG DOSING REGIMEN

The present invention relates to a method of treating immune thrombocytopenia (ITP) by administering eltrombopag or a pharmaceutically acceptable salt thereof to a patient. La présente invention concerne une méthode de traitement de la thrombocytopénie immunitaire (ITP) par administration d'elt...

Full description

Saved in:
Bibliographic Details
Main Authors GHANIMA, WALEED, ZAJA, FRANCESCO, COOPER, NICHOLA, STANKOVIC, MIONA
Format Patent
LanguageEnglish
French
Published 19.11.2020
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to a method of treating immune thrombocytopenia (ITP) by administering eltrombopag or a pharmaceutically acceptable salt thereof to a patient. La présente invention concerne une méthode de traitement de la thrombocytopénie immunitaire (ITP) par administration d'eltrombopag ou d'un sel pharmaceutiquement acceptable de celui-ci à un patient.
Bibliography:Application Number: CA20193140137